
Ivermectin: Much More Than You Wanted To Know
Astral Codex Ten Podcast
00:00
Ivomecton vs Plus Ebo
Chaku et al lincoln post 24 patients in spain were randomized to receive either medium dose ivomecton or plus ebo. Primary outcome was % of tons with negative p cr at day seven. Secondary outcomes were viral load and symptoms. The primary end point ended up being kind of a wash. Ivormecton trended towards lower viral dose load, but never reached significance.
Transcript
Play full episode